CAS 6556-11-2
:Inositolnicotinat
- 3-Pyridinecarboxylic acid, 1,2,3,4,5,6-cyclohexanehexayl ester
- Cyclohexane-1,2,3,4,5,6-Hexayl Hexapyridine-3-Carboxylate
- Dilcit
- Dilexpal
- Esantene
- Hamovannid
- Hexanicit
- Hexanicotinoyl inositol
- Hexanicotol
- Hexopal
- Inositol Hexanicotinate
- Inositol Nicotinate
- Inositol hexaniacinate
- Inositol, hexanicotinate, myo-
- Linodil
- Meso-inositol hexanicotinate
- Mesonex
- Mesotal
- Myo-Inositol Hexanicotinate
- Nicotinic acid, hexaester with myo-inositol
- Palohex
- Weitere Synonyme anzeigen
Inositol Niacinate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormel:C42H30N6O12Farbe und Form:Off-White PowderMolekulargewicht:810.19217myo-Inositol, hexa-3-pyridinecarboxylate
CAS:Formel:C42H30N6O12Reinheit:97%Farbe und Form:SolidMolekulargewicht:810.7206myo-Inositol hexanicotinate
CAS:Formel:C42H30N6O12Reinheit:≥ 98.0%Farbe und Form:White to off-white powderMolekulargewicht:810.72Rel-(1R,2R,3S,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-Hexayl Hexanicotinate
CAS:Rel-(1R,2R,3S,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-Hexayl HexanicotinateReinheit:97%Molekulargewicht:810.72g/molInositol nicotinate
CAS:Inositol nicotinate (Mesotal) has the effect of lowering cholesterol and expanding peripheral blood vessels for hypercholesterolemia and atherosclerosis.Formel:C42H30N6O12Reinheit:97.33%Farbe und Form:White PowderMolekulargewicht:810.72myo-Inositol Hexanicotinate
CAS:Kontrolliertes ProduktApplications myo-Inositol Hexanicotinate is an nicotinate conjugate of myo-inositol, an structural basis for a number of secondary messengers.
References Harsha, K.P., et al.: J. Pharma. Res., 4, 217 (2011); Vilar, S., et al.: J. Med. Chem., 49, 1118 (2006);Formel:C42H30N6O12Farbe und Form:Off-WhiteMolekulargewicht:810.72Inositol nicotinate
CAS:Inositol nicotinate is a combination of two substances, inositol and nicotinate. It is used to reduce the risk of heart disease by lowering low-density lipoprotein-cholesterol (LDL) levels. Inositol nicotinate has been shown to increase the surface area of mitochondria, which may be due to its ability to inhibit the release of fatty acids from fat cells. Inositol nicotinate also increases magnesium levels in cells and induces mitochondrial functions. This drug has been tested in cell culture for its effects on skin cells and found that it can reduce the amount of x-linked adrenoleukodystrophy protein (XALD), a substance that accumulates in patients with X-linked adrenoleukodystrophy, an inherited disorder that causes progressive damage to the nervous system. The drugs also have been shown to have beneficial effects on cholesterol metabolism, reducing LDL cholesterol levels, as well as inhibiting platelet aggregation.
Formel:C42H30N6O12Reinheit:Min. 95%Farbe und Form:White PowderMolekulargewicht:810.72 g/mol










